In addition, HSC ferroptosis is also implicated in other human diseases characterized by HSC loss such as Fanconi anemia and aplastic anemia [52], highlighting a broader therapeutic potential of IGF1 in a number of BM failure syndromes. The gene discussed is IGF1; the disease is aplastic anemia.